Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-16-138764
Date:2016-08-24
Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
Original Submission Date:

Reporting Person:

BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE BOSTON, MA 02210

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2016-08-24 M 6,500 a $36.30 274,725 direct
COMMON STOCK 2016-08-24 S 1,100 d $96.73 273,625 direct
COMMON STOCK 2016-08-24 S 1,000 d $98.74 272,625 direct
COMMON STOCK 2016-08-24 S 100 d $99.50 272,525 direct
COMMON STOCK 2016-08-24 S 1,500 d $101.21 271,025 direct
COMMON STOCK 2016-08-24 S 2,800 d $101.83 268,225 direct
COMMON STOCK 2016-08-24 S 100 d $100.02 79,100 indirect
COMMON STOCK 2016-08-24 S 900 d $101.60 78,200 indirect
COMMON STOCK 2016-08-24 0 $0.00 13,286 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 36.3 2016-08-24 deemed execution date M 6,500 (d) 2017-01-23 common stock 6,500 $36.30 131,500 direct
Footnotes
IDfootnote
f1 transaction made pursuant to the holder's company approved trading plan under rule 10b5-1.
f2 the holder undertakes to provide (upon request by the sec staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
f3 open market sales reported on this line occurred at a weighted average price of $96.73 (range $96.40 to $97.37).
f4 open market sales reported on this line occurred at a weighted average price of $98.74 (range $98.37 to $99.19).
f5 open market sales reported on this line occurred at a weighted average price of $101.21 (range $100.63 to $101.60).
f6 open market sales reported on this line occurred at a weighted average price of $101.83 (range $101.63 to $102.45).
f7 open market sales reported on this line occurred at a weighted average price of $101.60 (range $101.25 to $102.00).
f8 fully vested.
WhaleWisdom Logo

Elevate your investments